Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by UniSuper Management Pty Ltd

UniSuper Management Pty Ltd boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 157.6% in the 1st quarter, Holdings Channel reports. The firm owned 7,250 shares of the medical equipment provider’s stock after buying an additional 4,436 shares during the period. UniSuper Management Pty Ltd’s holdings in Intuitive Surgical were worth $2,893,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Provence Wealth Management Group acquired a new stake in Intuitive Surgical during the fourth quarter valued at approximately $276,000. Portside Wealth Group LLC lifted its position in shares of Intuitive Surgical by 8.2% in the 4th quarter. Portside Wealth Group LLC now owns 816 shares of the medical equipment provider’s stock valued at $275,000 after acquiring an additional 62 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in shares of Intuitive Surgical by 58.0% in the 4th quarter. Sequoia Financial Advisors LLC now owns 8,315 shares of the medical equipment provider’s stock valued at $2,805,000 after acquiring an additional 3,054 shares in the last quarter. Public Employees Retirement System of Ohio lifted its position in shares of Intuitive Surgical by 5.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 191,283 shares of the medical equipment provider’s stock valued at $64,531,000 after acquiring an additional 9,869 shares in the last quarter. Finally, HCR Wealth Advisors lifted its position in shares of Intuitive Surgical by 26.3% in the 4th quarter. HCR Wealth Advisors now owns 1,042 shares of the medical equipment provider’s stock valued at $352,000 after acquiring an additional 217 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 1,498 shares of Intuitive Surgical stock in a transaction dated Friday, April 26th. The shares were sold at an average price of $369.92, for a total transaction of $554,140.16. Following the completion of the transaction, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at approximately $2,037,149.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Intuitive Surgical news, Director Mark J. Rubash sold 1,709 shares of the firm’s stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $380.00, for a total value of $649,420.00. Following the completion of the sale, the director now owns 16,051 shares in the company, valued at approximately $6,099,380. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 1,498 shares of the firm’s stock in a transaction dated Friday, April 26th. The shares were sold at an average price of $369.92, for a total transaction of $554,140.16. Following the completion of the sale, the executive vice president now owns 5,507 shares of the company’s stock, valued at approximately $2,037,149.44. The disclosure for this sale can be found here. Insiders sold 10,638 shares of company stock valued at $4,214,441 in the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $6.06 during midday trading on Tuesday, reaching $455.06. 1,752,094 shares of the company’s stock were exchanged, compared to its average volume of 1,557,513. The company’s 50 day simple moving average is $425.07 and its two-hundred day simple moving average is $396.62. The firm has a market capitalization of $161.41 billion, a PE ratio of 82.14, a price-to-earnings-growth ratio of 5.87 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $468.78.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same period last year, the firm earned $1.18 EPS. The firm’s revenue for the quarter was up 14.5% compared to the same quarter last year. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on ISRG shares. Robert W. Baird upped their price target on shares of Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research report on Friday. BTIG Research upped their price target on shares of Intuitive Surgical from $451.00 to $459.00 and gave the company a “buy” rating in a research report on Monday, July 15th. Citigroup upped their price target on shares of Intuitive Surgical from $462.00 to $512.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Truist Financial increased their target price on shares of Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research report on Tuesday, July 16th. Finally, Piper Sandler increased their target price on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $438.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.